| Previous Close | 62.089 |
| Open | 62.070 |
| Bid | 61.080 x 500 |
| Ask | 61.840 x 500 |
| Day's Range | 61.244 - 61.983 |
| 52 Week Range | 53.550 - 66.190 |
| Volume | 4,051 |
| Avg. Volume | 21,712 |
| Net Assets | 136.41M |
| NAV | 60.63 |
| PE Ratio (TTM) | N/A |
| Yield | 1.72% |
| YTD Return | -0.78% |
| Beta (3y) | 1.01 |
| Expense Ratio (net) | 0.15% |
| Inception Date | 2009-09-22 |
Strattera, a drug for attention-deficit hyperactivity disorder, reported a 4% increase in revenues to $196.2 million in 1Q17, compared to $188.1 million in 1Q16.